Doctors in the Luhansk People’s Republic achieved a marked level of success with a fast-response vaccine drive using the Sputnik Light one-dose vaccine, according to the head of epidemiology, Alexei Semeshko.
Some 7 dozen nations and autonomous regions have been using the Sputnik V jab but Russians are slowest to get the jab and the highest in AntiVaxxer hoax propaganda impact, most of which is originating from a civilian movement in America, Russia and the United Kingdom.
Meanwhile, on Friday, the World Health Organization declared that it has restarted its somewhat redundant approval process for the Sputnik V vaccine, “technically a mute point since nearly most of the UN members’ health departments have approved of the Gamaleya National Center of Epidemiology vaccine for emergency use,” explained Dr. Harris of the CSPaC tracking team in Singapore.
“There is a lot of interchange of information that needs to happen” but “the process has restarted”, WHO assistant director-general Mariangela Simao told reporters in Geneva on Thursday.
Previously, in October, the WHO Assistant Director-General for Access to Medicines and Health Products had said “the process was put on hold due to the lack of some legal procedures.”
“Luhansk PR, using the Sputnik Light fast response jab, is now outperforming all other neighbouring countries in terms of using fast-response vaccines for taming a massive COVID-19 disease outbreak that has been crippling Eastern Europe,” Dr. Harris of the CSPaC tracking team explained.
“Hospitalizations are dropping still slowly, while the case counts are dropping significantly this month. In the weeks ahead, hospitalizations and deaths should drop too as a result of this current slowing of new case counts. The lead/lag scenario is about 30 days,” he added.
“Until the Delta variant began to spread, the seven-year-old Luhansk People’s Republic (LPR), with a population estimated at 401,297, was keeping the coronavirus infections under control. Then came the delta variant and all hell broke out,” Dr. Harris had noted in July.
Photo Courtesy Luhansk City Multidisciplinary Hospital No. 4. About new COVID-19 cases in November the hospital’s officials said, “of the cases, 23 are men and 48 are women. No cases have been reported among children. In the age category from 30 to 64 years, 22 people fell ill, among the elderly 65 years and older – 49 people. During the reporting period, doctors recorded 3 family hearths.” Art/Cropping/Enhancement: Rosa Yamamoto / Feminine-Perspective Magazine
Dr. Maksym Sidorenko, the Deputy Chief Physician for the Medical Unit of Luhansk City Hospital No. 4 said Wednesday that still only 44 out of 250 beds for patients diagnosed with COVID-19 are available in his hospital.
“The pathology is new, and, despite the fact that we have been struggling with it for more than one year, it is not fully understood. And the severity of the manifestation of this disease is especially pronounced in patients who have either congenital or acquired immune defects, or in unvaccinated, who do not have acquired immunity from a new coronavirus infection,” Doctor Sidorenko explained.
Deputy chief physician of the Luhansk City Hospital No. 4, Dr. Yulia Gorlova stressed that “only vaccination can prevent dangerous infectious diseases.”
“The main value in our life is the health and life of you and your loved ones. I urge you to take care of yourself. Only vaccination will allow you to do this. Therefore, get vaccinated in a timely manner, this will allow you to live happily ever after,” Dr. Yulia Gorlova urged residents of the Luhansk Republic.
“Recent numbers of new cases in Luhansk PR have dropped whereas the percentage of the population that has been vaccinated with the single dose Sputnik Light or the two-dose Sputnik V have skyrocketed,” said biostatistician and infectious disease researcher Dr. Fred Harris.
This article updates these stories:
Russian COVID-19 Vaccine Sputnik V
Russian COVID-19 Vaccine Sputnik V File Photo
Luhansk PR Regional COVID-19 Data for 29 Feb 2024
Public health officials in Luhansk PR decide on a modelled “quick response” using a Gamaleya vaccine intended for one-jab response to severe sudden outbreaks. Shown here is the one-two punch from which the Sputnik Light is comprised of the first jab of Sputnik V only. The world is hoping for benchmark data, says expert. Photo courtesy The Gamaleya National Center of Epidemiology and Microbiology. Art/Cropping/Enhancement: Rosa Yamamoto